Screen the market. Value any stock.

Neither. ACCE is a research platform: we publish valuation data, indices, and analysis that you use in your own research. We are not a registered investment adviser, and nothing on ACCE is personalized financial advice. Think of us as the research desk; your brokerage is the trading desk.

Each index is a curated basket of stocks organized around a thesis: AI Infrastructure, Defense, Cybersecurity, and so on. The founder personally builds, reviews and approves every index. AI assists with research and screening, but a person makes the final call on every constituent, weight, and rebalance. We publish the full methodology, track daily NAV against the S&P 500, and rebalance on triggers, not calendars. You do not buy the index. You follow it and replicate the positions that match your risk profile.

Free gives you 5 full stock pages a month that show everything (all valuation models, scenarios, fair value history, AI notes and the four questions). Every other stock page still shows the fair value, a plain-language verdict and the model range, AI notes with their sources and the insider and Congress summary. Free also includes email alerts on any stock, index performance and the basic screener. Investor opens every stock page in full: the four questions, the DCF with its assumptions and its bad, normal and good cases, what moves the value most, why the fair value changed, a reason under every score and score history, plus the 8-quarter beat and miss chart, SEC filings with summaries, 5-metric fundamental charts, a 10-holding portfolio and the weekly digest. Pro adds every valuation model with its assumptions and why it counts, the editable DCF workbench, every insider, Congress and 13F trade, the AI Coach, live Q&A and Steel-Man, the enriched thesis, 19-metric charts with the analyst forecast cone, the full screener, an unlimited portfolio, portfolio insights and PDF research reports. Desk adds power tools: multi-stock comparison, private notes per stock, Monte Carlo simulation, correlation matrix, tax-loss harvesting, monthly and quarterly review emails and priority support.

Every stock page opens with a plain-language verdict: the fair value, the range the models give and how many of them agree. Below it come four plain questions, a "?" next to the key numbers, where each model lands with its assumptions and why it counts, bad, normal and good cases, what moves the value most, and a log of why the fair value changed. You also get the ACCE score with a reason under each score and its history, AI notes that cite their sources (a claim without a source is not published), insider and Congress trades with the disclosure delay, the fair value of each peer, a France and Spain card (PEA, account type, dividend withholding) and the next earnings date to add to your calendar. Investor sees the DCF in full; Pro sees every model, the editable DCF workbench and the full trade lists.

Every claim is grounded in current price, market cap, and the output of our systematic multi-model valuation engine for that stock. The model that writes the thesis is locked to four specific tasks: identify where consensus is likely wrong, the narrative risks the systematic models cannot capture, qualitative catalysts that could re-rate the stock, and what would actually invalidate the thesis. It complements the deterministic valuation, it is not a general-purpose chatbot, and it cannot quote numbers we have not given it.

A human does the work, with AI assisting. Our models handle the heavy quantitative lifting (screening thousands of stocks, running financial models, scoring fundamentals and momentum) so the founder can focus on judgment: checking the assumptions, weighing the catalysts, and personally reviewing every index rebalance and constituent change.

Global equities across US, European, Canadian, and Asia-Pacific exchanges: NYSE, NASDAQ, LSE, XETRA, Euronext (Paris/Amsterdam/Brussels), SIX Swiss, Borsa Italiana, BME (Madrid), Nordic exchanges, TSX, Tokyo, Hong Kong, ASX, Singapore, Taiwan, Korea, and NSE (India). The screener carries thousands of names across these markets, with ~80 curated for deep research coverage and index inclusion. SEC EDGAR filings auto-attach to any dual-listed foreign filer; full per-regulator local filing integration (BaFin, AMF, SEDAR+, EDINET, ASX disclosures, HKEX, etc.) is on the roadmap.

Equities only. We focus on stocks because that's where our quantitative models and fundamental analysis add the most value. We have no plans to cover crypto or derivatives; there are better tools for those if that's what you need.

No. ACCE is a research tool and does not execute trades; any brokerage that gives you access to the relevant exchange works: Interactive Brokers, Schwab, Trade Republic, Degiro, Saxo, whatever you already use. Interactive Brokers tends to offer the broadest international access at the lowest cost; Trade Republic and Degiro are strong in Europe; Schwab/Fidelity for US-focused investors. Make sure your broker covers the listing venues you care about (e.g. LSE for UK names, XETRA for German, TSX for Canadian).

Everything runs on UTC. Price and valuation updates run daily between 21:00 and 23:00 UTC, after US market close. Email digests send Monday 08:00 UTC. All timestamps in the app are displayed in your local time zone.

Yes. Investor and Pro users can upload a CSV or Excel file with your transactions (ticker, date, buy/sell, shares, price, fees). We provide a template. The system auto-backfills dividends and stock splits, computes cost basis, and gives you a full P&L view. Pro users also get insights on concentration, sector balance, and overlap with ACCE indices.

No. Zero. We don't accept payment, sponsorship, or any form of compensation from companies featured in our indices or analysis. Revenue comes exclusively from subscriptions. If a company offered us money to cover them, we'd decline and probably write about why.

Three things: methodology, transparency, and incentives. We publish the models and assumptions behind every fair value, not just a verdict. Every headline fair value is saved daily so it can be checked against what the market did next. And our revenue comes from subscriptions, not engagement, sponsorships, or affiliate deals. We make more money when subscribers stay because the research is good, not because the content is viral.

Yes. Cancel online from your account (Profile, Plans & Billing), no phone calls and no email to send. You keep access through the end of your current billing period, then drop to Free. Annual plans cancel at the end of the year.

No refunds, apart from the 14-day right of withdrawal set out in our Terms. Every new account starts with a 30-day free trial that needs no card, so you can test the product before you pay anything. If you pick a plan during the trial, nothing is charged before your trial ends, and we email you 7 and 3 days before the first charge with a link straight to the cancel screen. After that, cancel any time to stop future billing (you keep access until the current period ends).

Yes. Every new account starts a 30-day free trial with full access and no card (AI questions are not included). When it ends, your account returns to the free plan unless you pick a plan, and picking one during the trial charges nothing before the trial end date. We email you 7 and 3 days before it ends. There is also the free account, no card required: 5 full stock pages every month plus the screener and index performance, free forever. Want Ask ACCE as well? Start the AI trial instead: pick a plan, add your card and pay 1 USD to activate it. You get 30 days and 1,500 AI tokens, and the 1 USD is deducted from your first payment.

Yes. ACCE is a research and information platform, not a broker or advisor. You can subscribe from any country. Coverage spans US, European, Canadian, and Asia-Pacific exchanges, so subscribers worldwide find names listed where they actually trade. Your ability to buy any specific stock depends on your local brokerage and regulations. Check with your broker if you're unsure about access to specific markets.

Your portfolio data and saved screens are retained for 90 days after cancellation in case you resubscribe. After that, they're permanently deleted. Your account email and subscription history are retained for legal/accounting purposes. You can request full data deletion at any time via email; we comply within 72 hours. We're GDPR-compliant: no data selling, no third-party sharing, no ad targeting.

If we ever wind down, active subscribers get at least 30 days notice and a prorated refund on any unused subscription period. You'd be able to export all portfolio data and saved screens as CSV before shutdown. We're a funded, revenue-generating business, but you deserve to know the contingency plan.